These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22871579)

  • 1. Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4.
    Bhaskar Kumar T; Sumanth Ch; Vaishaly S; Srinivasa Rao M; Chandra Sekhar KB; Meda CL; Kandale A; Rambabu D; Rama Krishna G; Malla Reddy C; Shiva Kumar K; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5639-47. PubMed ID: 22871579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pd-mediated new synthesis of pyrroles: their evaluation as potential inhibitors of phosphodiesterase 4.
    Reddy GR; Reddy TR; Joseph SC; Reddy KS; Reddy LS; Kumar PM; Krishna GR; Reddy CM; Rambabu D; Kapavarapu R; Lakshmi C; Meda T; Priya KK; Parsa KV; Pal M
    Chem Commun (Camb); 2011 Jul; 47(27):7779-81. PubMed ID: 21643571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
    Ram Reddy T; Rajeshwar Reddy G; Srinivasula Reddy L; Jammula S; Lingappa Y; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Eur J Med Chem; 2012 Feb; 48():265-74. PubMed ID: 22217868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montmorillonite K-10 catalyzed green synthesis of 2,6-unsubstituted dihydropyridines as potential inhibitors of PDE4.
    Reddy TR; Reddy GR; Reddy LS; Meda CL; Parsa KV; Kumar KS; Lingappa Y; Pal M
    Eur J Med Chem; 2013 Apr; 62():395-404. PubMed ID: 23380174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
    Gorja DR; Shiva Kumar K; Kandale A; Meda CL; Parsa KV; Mukkanti K; Pal M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2480-7. PubMed ID: 22381049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
    Kumar KS; Kiran Kumar S; Yogi Sreenivas B; Gorja DR; Kapavarapu R; Rambabu D; Rama Krishna G; Reddy CM; Basaveswara Rao MV; Parsa KV; Pal M
    Bioorg Med Chem; 2012 Apr; 20(7):2199-207. PubMed ID: 22386978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
    Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
    Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
    Mareddy J; Nallapati SB; Anireddy J; Devi YP; Mangamoori LN; Kapavarapu R; Pal S
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6721-7. PubMed ID: 24215890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
    Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
    Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel imidazophenoxazine-4-sulfonamides: their synthesis and evaluation as potential inhibitors of PDE4.
    Reddy SV; Rao GM; Kumar BV; Meda CL; Deora GS; Kumar KS; Parsa KV; Pal M
    Bioorg Med Chem; 2013 Apr; 21(7):1952-63. PubMed ID: 23415088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel thieno[2,3-d]pyrimidines: their design, synthesis, crystal structure analysis and pharmacological evaluation.
    Adepu R; Rambabu D; Prasad B; Meda CL; Kandale A; Krishna GR; Reddy CM; Chennuru LN; Parsa KV; Pal M
    Org Biomol Chem; 2012 Aug; 10(29):5554-69. PubMed ID: 22710638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-free Pd-catalyzed C-N cross-coupling/cyclization strategy: an unprecedented access to 1-thienyl pyrroloquinoxalines for the new approach towards apoptosis.
    Kolli SK; Nakhi A; Archana S; Saridena M; Deora GS; Yellanki S; Medisetti R; Kulkarni P; Ramesh Raju R; Pal M
    Eur J Med Chem; 2014 Oct; 86():270-8. PubMed ID: 25171781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally restricted novel pyrazole derivatives: synthesis of 1,8-disubstituted 5,5-dimethyl-4,5-dihydro-1H-benzo[g]indazoles as a new class of PDE4 inhibitors.
    Reddy TS; Kumar KS; Meda CL; Kandale A; Rambabu D; Krishna GR; Hariprasad C; Rao VV; Venkataiah S; Reddy CM; Naidu A; Dubey PK; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 May; 22(9):3248-55. PubMed ID: 22464134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): a new strategy to identify inhibitors of PDE4B.
    Pal S; Durgadas S; Nallapati SB; Mukkanti K; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6573-6. PubMed ID: 21920740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
    Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.
    Gorja DR; Mukherjee S; Meda CL; Deora GS; Kumar KL; Jain A; Chaudhari GH; Chennubhotla KS; Banote RK; Kulkarni P; Parsa KV; Mukkanti K; Pal M
    Org Biomol Chem; 2013 Apr; 11(13):2075-9. PubMed ID: 23436140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
    Purushothaman B; Arumugam P; Kulsi G; Song JM
    Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selaginpulvilins A-D, new phosphodiesterase-4 inhibitors with an unprecedented skeleton from Selaginella pulvinata.
    Liu X; Luo HB; Huang YY; Bao JM; Tang GH; Chen YY; Wang J; Yin S
    Org Lett; 2014 Jan; 16(1):282-5. PubMed ID: 24328835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Assisted One-pot and Sequential Synthesis of 3-methylene-isoindolin-1-ones and their in vitro Evaluation.
    Suman K; Bharath Y; Anuradha V; Rao MVB; Pal M
    Mini Rev Med Chem; 2018; 18(17):1498-1505. PubMed ID: 28758576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.